Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics

Journal of Internal Medicine

Volumn 247, Issue 1, 2000, Pages 43-52

  Nielsen, Niels Erik ^a   Olsson, A G ^a   Swahn, E ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Lipoprotein particles; ROC; Unstable CAD; Women

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

AGED; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; LIPOPROTEINS; MIDDLE AGED; POSTMENOPAUSE; ROC CURVE; TRIGLYCERIDES;

EID: 0033969434     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00567.x     Document Type: Article

References (40)

1. 1 Friedewald W. Levy R. Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
2. 2 Alaupovic P. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA-and ApoB-containing lipoprotein families. Prog Lipid Res 1991; 30; 105-38.
3. 3 Kottke B, Zinsmeister A, Holmes DJ, Kneller R, Hallaway B. Mao S. Apolipoproteins and coronary artery disease. Mayo Clin Proc 1986; 61: 313-20.
4. 4 Schmidt S, Wasserman A, Muesing R. Schlesselman S, Larosa J, Ross A. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. Am J Cardial 1985: 55: 1459-62.
5. 5 Puchois P, Kandoussi A, Fievet P, et al. Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis 1987; 68: 35-40.
6. 6 Barbaras R, Puchois P, Fruchart J, Ailhaud G. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI. All particles. Biochem Biophys Res Commun 1987; 142: 63-9.
7. 7 Alaupovic P, Blankenhorn D. Determination of potentially atherogenic triglyceride-rich lipoprotein particles. Klin Wochenschr 1990; 68: 38-42.
8. 8 Blankenhorn D, Alaupovic P, Wickham E, Chin H, Azen S. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation 1990; 81: 470-6.
9. 9 Hodis H. Mack W, Azen S, et al. Triglyceride-and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 1994; 90: 42-9.
10. 10 Tornvall P, Bavenholm P, Landou C, de Faire U, Hamsten A. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation 1993; 88: 2180-9.
11. 11 Hamsten A. Lipids as a coronary risk factor: analysis of hyperlipidaemias. Postgrad Med J 1993; 69: S8-11.
12. 12 Alaupovic P, Knight-Gibson C, Wang C, et al. Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-ll. B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia. J Lipid Res 1991; 32: 9-19.
13. 13 Alaupovic P, Tavella M, Bard J, et al. Lipoprotein particles in hypertriglyceridemic states. Adv Exp Med Biol 1988; 243: 289-97.
14. 14 Bostom A, Gagnon D, Cupples L, Wilson PW, Jenner JL, Ordovas J. M, et al. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation 1994; 90: 1688-95.
15. 15 Brown M, Goldstein J. Plasma lipoproteins: teaching old dogmas new tricks [news]. Mature 1987; 330: 113-4.
16. 16 Dahlen G, Guyton J, Attar M, Farmer J. Kautz J, Gotto AJ. Association of levels of lipoprotein Lp (a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758-65.
17. 17 Hearn J, DeMaio SJ, Roubin G, Hammarstrom M, Sgoutas D. Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographie diagnosis of coronary artery disease. Am J Cardiol 1990; 66: 1176-80.
18. 18 Rhoads GG, Dahlen G, Berg K. Morton NE. Dannenberg AL. Lp (a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256: 2540-4.
19. 19 Barbagallo C, Averna M, Fradá G, Chessari S, Mangiacavallo G, Notarbartolo A. Plasma lipid, apolipoprotein and Lp (a) levels in elderly normolipidemic women: Relationships with coronary heart disease and longevity. Gerontology 1995; 41: 260-6.
20. 20 Swahn E, von Schenk H. Prognostic importance of plasma lipoprotein - analyses in patients with unstable coronary artery disease. Scand J Clin Lab Invest 1993; 53: 289-95.
21. 21 Genest J, Bard J, Fruchart J, Ordovas J, Wilson P, Schaefer E. Plasma apolipoprotein A-I, A-II. B,E and C-III containing particles in men with premature coronary artery disease. Atherosclerosis 1991; 90: 149-57.
22. 22 Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 1992; 70: 733-7.
23. 23 Chivot L, Masinard F, Bigot E, et al. Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E. Atherosclerosis 1990; 82: 205-11.
24. 24 Koren E, Corder C, Mueller G, et al. Triglyceride enriched lipoprotein particles correlate with the severity of coronary-artery disease. Atherosclerosis 1996; 122: 105-15.
25. 25 Kwiterovich P, Coresh J, Smith H, Bachorik P, Derby C, Pearson T. Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol 1992; 69: 1015-21.
26. 26 Kannel W, Wilson P. Efficiacy of lipid profiles in prediction of coronary disease. Am Heart J 1992; 124: 768-74.
27. 27 Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: Predicting risks by levels and ratios. Ann Intern Med 1994; 121: 641-7.
28. 28 Wald N. Law M, Watt H, et al. Apolipoproteins and ischaemic heart disease: implications for screening. Lancet 1994; 343: 75-9.
29. 29 Sedlis S, Schechtman K, Ludbrook P, Sobel B, Schonfeld G. Plasma apoproteins and the severity of coronary artery disease. Circulation 1986; 73: 978-86.
30. 30 Johansson J, Carlson LA, Landou C, Hamsten A. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 1991; 11: 174-82.
31. 31 Tornvall P, Karpe F, Proudler A, et al. High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease. Metabolism 1996; 45: 1375-82.
32. 32 Grover SA, Palmer CS, Coupal L. Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort. Arch Intern Med 1994; 154: 679-84.
33. 33 Grover SA. Coupal L, Hu XP. Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work? JAMA 1995; 274: 801-6.
34. 34 Avins AL, Browner WS. Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels: what a difference a decade makes. JAMA 1998; 279: 445-9.
35. 35 Zweig MH. Apolipoproteins and lipids in coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristic plots and areas. Arch Pathol Lab Med 1994; 118: 141-4.
36. 36 Metz CE. Some practical issues or experimental design and data analysis in radiological ROC studies. Invest Radiol 1989; 24: 234-15.
37. 37 CASS Study Croup. National Heart Lung. Blood Institute Coronary Artery Surgery Study (CASS). Circulation 1981; 63 ().
38. 38 Anonymous. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet 1996; 347: 561-8.
39. 39 Swets JA. Measuring the accuracy of diagnostic systems. Science 1988; 240: 1285-93.
40. 40 Rosenson R. Myocardial injury: The acute phase response and lipoprotein metabolism. JACC 1993; 22: 933-40.